p53 can inhibit the transcription of the systemic xc– subunit SLC7A11 (Jiang et al., 2015; Wang et al., 2016), and P47S amino acid mutation of p53 was reported to confer resistance to ferroptosis, thus promoting tumor formation (Jennis et al., 2016). Here, TP53 is linked to neoplasm.